Abstract
Objective To observe the therapeutic effects of riboflavin-ultraviolet A (UVA) corneal collagen cross-linking (CXL) performed with a transepithelial method for progressive keratoconus. Methods This was a prospective case series study. Thirty-six patients (54 eyes) with progressive keratoconus who underwent transepithelial corneal collagen cross-linking surgery were reviewed. The procedure was performed under topical anesthesia using a transepithelial corneal collagen cross-linking instrument (SOFT , Italy). riboflavin (0.25%) was imported into the cornea for 10 minutes (current 1.0 mA). The irradiation was performed for 9 minutes using a solid-state UVA illuminator at 370 nm and an irradiance of 10 mW/cm2. The average follow-up time was 14.1±2.3 months. Corneal epithelium healing was observed 1 day after surgery. There were no complications such as corneal ulcer, corneal dissolution, corneal epithelium mist opacity (haze) or severe pain. Uncorrected visual acuity (UCVA) ; best corrected visual acuity (BCVA) ; intraocular pressure ; corneal curvature ; corneal thickness; corneal topography; endothelial cell count; corneal biomechanical properties and in vivo confocal microscopy were evaluated at baseline and at 1, 3, 6, 12 months postoperatively. Data were analyzed using a paired samplest test. Results The day after surgery, the corneal epithelium had opaque spots due to edema but the condition improved by the second day. Postoperative 12 months, UCVA and BCVA increased from 4.27±0.23 to 4.41±0.20 (t=3.962,P<0.01) and from 4.69±0.23 to 4.82±0.14 (t=3.507,P<0.01), respectively. Interim analysis of a flattening of the steepest simulated keratometry value (K-max) and astigmatism by an average of 1.25±0.68 diopters (t=9.351, P<0.01) and 0.30±0.21 diopters (t=7.227, P<0.01) . The deformation amplitude decreased from 1.21±0.11 mm to 1.16±0.12 mm (t=4.131, P<0.01) . Intraocular pressure, endothelial cell count and central corneal thickness did not change significantly. Conclusion Transepithelial corneal collagen cross-linking can significantly control the development of progressive keratoconus and do not have any of the complications that develop from the traditional epithelium-off method. Therefore, the transepithelial corneal collagen cross-linking method is safe and effective, and is expected to replace the traditional epithelium-off method to become the preferred treatment for progressive keratoconus. Key words: Corneal collagen cross-linking; Keratoconus; Transepithelial methods
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.